The Types and Proportions of Commensal Microbiota Have a Predictive Value in Coronary Heart Disease

Overview

Journal J Clin Med

Specialty General Medicine

Date 2021 Jul 24

PMID 34300286

Citations 7

Authors

Lin Chen

Tomoaki Ishigami

Hiroshi Doi

Kentaro Arakawa

Kouichi Tamura

Affiliations

Soon will be listed here.

Abstract

Previous clinical studies have suggested that commensal microbiota play an important role in atherosclerotic cardiovascular disease; however, a synthetic analysis of coronary heart disease (CHD) has yet to be performed. Therefore, we aimed to investigate the specific types of commensal microbiota associated with CHD by performing a systematic review of prospective observational studies that have assessed associations between commensal microbiota and CHD. Of the 544 published articles identified in the initial search, 16 publications with data from 16 cohort studies (2210 patients) were included in the analysis. The combined data showed that Bacteroides and Prevotella were commonly identified among nine articles ( = 13) in the fecal samples of patients with CHD, while seven articles commonly identified Firmicutes. Moreover, several types of commensal microbiota were common to atherosclerotic plaque and blood or gut samples in 16 cohort studies. For example, Veillonella, Proteobacteria, and Streptococcus were identified among the plaque and fecal samples, whereas Clostridium was commonly identified among blood and fecal samples of patients with CHD. Collectively, our findings suggest that several types of commensal microbiota are associated with CHD, and their presence may correlate with disease markers of CHD.

Citing Articles

Changes of Intestinal Flora in Patients with Atrial Fibrillation and Its Correlation with Cardiovascular Risk Factors.

Chen S, Tu M, Shi J, Hu X Rev Cardiovasc Med. 2024; 24(4):110.

PMID: 39076278 PMC: 11273065. DOI: 10.31083/j.rcm2404110.

The Mediterranean Diet, Its Microbiome Connections, and Cardiovascular Health: A Narrative Review.

Abrignani V, Salvo A, Pacinella G, Tuttolomondo A Int J Mol Sci. 2024; 25(9).

PMID: 38732161 PMC: 11084172. DOI: 10.3390/ijms25094942.

Intestinal microbiota and metabolome perturbations in ischemic and idiopathic dilated cardiomyopathy.

Wang Y, Xie Y, Mahara G, Xiong Y, Xiong Y, Zheng Q J Transl Med. 2024; 22(1):89.

PMID: 38254195 PMC: 10804607. DOI: 10.1186/s12967-023-04605-6.

Characterization of gut microbiota in adults with coronary atherosclerosis.

Dong Y, Xu R, Chen X, Yang C, Jiang F, Shen Y PeerJ. 2023; 11:e15245.

PMID: 37220524 PMC: 10200099. DOI: 10.7717/peerj.15245.

Efficacy and Mechanism of Qianshan Huoxue Gao in Acute Coronary Syndrome via Regulation of Intestinal Flora and Metabolites.

Zhao N, Ma Y, Liang X, Zhang Y, Hong D, Wang Y Drug Des Devel Ther. 2023; 17:579-595.

PMID: 36855515 PMC: 9968440. DOI: 10.2147/DDDT.S396649.

References

Arakawa K, Ishigami T, Nakai-Sugiyama M, Chen L, Doi H, Kino T . Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice. PLoS One. 2019; 14(6):e0218096. PMC: 6576757. DOI: 10.1371/journal.pone.0218096. View

Fatkhullina A, Peshkova I, Dzutsev A, Aghayev T, McCulloch J, Thovarai V . An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis. Immunity. 2018; 49(5):943-957.e9. PMC: 6257980. DOI: 10.1016/j.immuni.2018.09.011. View

Zheng Y, Wu T, Liu Z, Li A, Guo Q, Ma Y . Gut Microbiome-Based Diagnostic Model to Predict Coronary Artery Disease. J Agric Food Chem. 2020; 68(11):3548-3557. DOI: 10.1021/acs.jafc.0c00225. View

Emoto T, Yamashita T, Kobayashi T, Sasaki N, Hirota Y, Hayashi T . Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease. Heart Vessels. 2016; 32(1):39-46. DOI: 10.1007/s00380-016-0841-y. View

Li C, Gao M, Zhang W, Chen C, Zhou F, Hu Z . Zonulin Regulates Intestinal Permeability and Facilitates Enteric Bacteria Permeation in Coronary Artery Disease. Sci Rep. 2016; 6:29142. PMC: 4926221. DOI: 10.1038/srep29142. View

Caesar R, Reigstad C, Backhed H, Reinhardt C, Ketonen M, Lunden G . Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut. 2012; 61(12):1701-7. PMC: 3505865. DOI: 10.1136/gutjnl-2011-301689. View

Zhang D, Chen G, Manwani D, Mortha A, Xu C, Faith J . Neutrophil ageing is regulated by the microbiome. Nature. 2015; 525(7570):528-32. PMC: 4712631. DOI: 10.1038/nature15367. View

Binder C, Horkko S, Dewan A, Chang M, Kieu E, Goodyear C . Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med. 2003; 9(6):736-43. DOI: 10.1038/nm876. View

Canducci F, Saita D, Foglieni C, Piscopiello M, Chiesa R, Colombo A . Cross-reacting antibacterial auto-antibodies are produced within coronary atherosclerotic plaques of acute coronary syndrome patients. PLoS One. 2012; 7(8):e42283. PMC: 3412836. DOI: 10.1371/journal.pone.0042283. View

10.

Campbell L, Kuo C . Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?. Nat Rev Microbiol. 2004; 2(1):23-32. DOI: 10.1038/nrmicro796. View

11.

Gao J, Yan K, Wang J, Dou J, Wang J, Ren M . Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events. Sci Rep. 2020; 10(1):2639. PMC: 7021689. DOI: 10.1038/s41598-020-59235-5. View

12.

Sato J, Kanazawa A, Ikeda F, Yoshihara T, Goto H, Abe H . Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes. Diabetes Care. 2014; 37(8):2343-50. DOI: 10.2337/dc13-2817. View

13.

Emoto T, Yamashita T, Sasaki N, Hirota Y, Hayashi T, So A . Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease. J Atheroscler Thromb. 2016; 23(8):908-21. PMC: 7399299. DOI: 10.5551/jat.32672. View

14.

Brown J, Hazen S . The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med. 2015; 66:343-59. PMC: 4456003. DOI: 10.1146/annurev-med-060513-093205. View

15.

Ghosh S, Bie J, Wang J, Ghosh S . Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-/- mice--role of intestinal permeability and macrophage activation. PLoS One. 2014; 9(9):e108577. PMC: 4177397. DOI: 10.1371/journal.pone.0108577. View

16.

Chen L, Ishigami T, Doi H, Arakawa K, Tamura K . Gut microbiota and atherosclerosis: role of B cell for atherosclerosis focusing on the gut-immune-B2 cell axis. J Mol Med (Berl). 2020; 98(9):1235-1244. PMC: 7447622. DOI: 10.1007/s00109-020-01936-5. View

17.

David L, Maurice C, Carmody R, Gootenberg D, Button J, Wolfe B . Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2013; 505(7484):559-63. PMC: 3957428. DOI: 10.1038/nature12820. View

18.

Saita D, Ferrarese R, Foglieni C, Esposito A, Canu T, Perani L . Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation. Sci Rep. 2016; 6:29353. PMC: 4935993. DOI: 10.1038/srep29353. View

19.

Liu H, Chen X, Hu X, Niu H, Tian R, Wang H . Alterations in the gut microbiome and metabolism with coronary artery disease severity. Microbiome. 2019; 7(1):68. PMC: 6486680. DOI: 10.1186/s40168-019-0683-9. View

20.

Casalta J, Fournier P, Habib G, Riberi A, Raoult D . Prosthetic valve endocarditis caused by Pseudomonas luteola. BMC Infect Dis. 2005; 5:82. PMC: 1274313. DOI: 10.1186/1471-2334-5-82. View